The Cleopatra study reports improvement in median survival of almost 16 months in patients with HER2-positive metastatic breast cancer The…
news
Source: Princess Margaret Cancer Centre TORONTO, Canada – Feb. 27, 2015 – Two internationally acclaimed cancer centres today announced a…
Source: Merck Serono Merck Serono and Sysmex Inostics Announce First Liquid Biopsy RAS Biomarker Testing Center Opens: Important Milestone for…
A study published in this month´s Nature Genetics, in which the Vall d’Hebron Institute of Oncology (VHIO) participated, has revealed…
• The latest round of ERC ´Proof of Concept´ Grants will further support existing ERC grant holders to advance research…
Ovarian cancer ranks fifth among cancer-related death in women. While the exact cause of ovarian cancer remains largely unknown, up…
Source: Union for International Cancer Control (UICC) New data projects that US$18 billion increase in funding per year by the…
The results of a clinical trial led by researchers at VHIO have established eribulin as effective therapy in patients with…
Barcelona, 28 January 2015. Today marks an important date in the diary for Joan Seoane, Director of Translational Research at…
• VHIO and the Weizmann Institute of Science provide a platform to exchange and debate latest research aimed at combating…
